体外膜氧合系统市场：按模式、按应用、按年龄组、按地区 - 规模、份额、前景、机会分析，2022-2030

体外膜肺氧合 (ECMO) 是一种在体外支持心肺功能的方法。根据引流和再灌注的位置，体外膜肺氧合系统分为动静脉、静脉-动脉和静脉三种类型。它们还根据年龄分为新生儿、儿童和成人使用。 ECMO 通过套管引流和回输端口的位置确定係统的模式。当引流和再灌注都来自中心静脉时，称为静脉ECMO，当从静脉到动脉时，称为静脉ECMO。 ECMO 对患有严重肺部或心脏病、等待心臟移植或从心臟移植中恢復的人很有用。当其他生命支持方式无效时，也可以使用它。 ECMO不能治癒疾病，但当组织不能提供足够的氧气时，它可以暂时帮助身体。

先天性心脏病发病率呈上升趋势，ECMO的需求量越来越大。例如，根据美国心臟协会的数据，美国每年约有 40,000 名婴儿出生时患有先天性心脏病，大约有 2 至 300 万人患有先天性心脏病。

市场动态

ECMO 市场增长的推动因素包括心血管疾病和慢性呼吸道疾病（如哮喘、慢性阻塞性肺病 (COPD)、职业性肺病和肺动脉高压）的患病率不断上升。例如，根据世界卫生组织公布的数据，到2022年5月，慢性阻塞性肺病（COPD）将成为全球第三大死因，2019年造成323万人死亡。

本研究的主要特点

• 本报告对全球体外膜氧合器市场进行了深入分析，包括以 2021 年为基准年的预测期内（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
• 解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
• 该研究还提供了有关市场驱动因素、抑制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
• 根据公司亮点、产品组合、关键亮点、财务业绩和战略等参数，对全球体外膜氧合系统市场的主要参与者进行简介。
• 本研究涵盖的主要公司包括 Medtronic、Getinge AB、LivaNova PLC、Terumo Corporation、XENIOS AG、OriGen Biomedical、EUROSETS NIPRO 和 MicroPort Scientific Corporation
• 本报告中的见解将使营销人员和企业高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
• 全球体外膜氧合系统市场报告包括投资者、供应商和产品
• 我们为该行业的各种利益相关者提供服务，包括製造商、分销商、新进入者和财务分析师。
• 利益相关者应通过用于分析全球体外膜氧合系统市场的各种战略矩阵来促进决策制定。

内容

第 1 章目的和先决条件

• 调查目的
• 先决条件
• 缩写说明

第二章市场展望

• 举报内容
  • 市场定义和范围
• 执行摘要
  • 按模式划分的市场概况
  • 市场快照：按应用
  • 市场概况：按年龄组
  • 市场概况：按地区划分
• 连贯的机会图 (COM)

第 3 章市场动态、监管和趋势分析

• 市场动态
  • 驱动程序
  • 约束因素
  • 市场机会
• 影响分析
• 市场趋势
• 技术进步
• PEST 分析
• 波特五力

第 4 章体外膜氧合系统全球市场 - 冠状病毒 (COVID-19) 大流行的影响

• 整体影响
• 对供需的影响
• COVID-19 对市场的影响

第 5 章全球体外膜氧合器市场：按模式分类，2017-2030

• 动静脉
• 静脉动脉
• 静脉

第 6 章全球体外膜氧合系统市场：按应用分类，2017-2030

• 体外心肺復苏术
• 心
• 呼吸系统

第 7 章按年龄组分列的全球体外膜氧合器市场：2017-2030

• 新生儿
• 儿科
• 成人

第 8 章全球体外膜氧合器市场：按地区分列，2017-2030

• 北美
• 美国
• 加拿大
• 拉丁美洲
• 巴西
• 墨西哥
• 阿根廷
• 其他拉丁美洲地区
• 欧洲
• 英国
• 德国
• 意大利
• 法国
• 西班牙
• 俄罗斯
• 其他欧洲
• 亚太地区
• 中国
• 印度
• 日本
• 东盟
• 澳大利亚
• 韩国
• 其他亚太地区
• 中东
• 海合会
• 以色列
• 其他中东
• 非洲
• 北非
• 中非
• 南非

第 9 章竞争格局

• Medtronic
• Getinge AB
• LivaNova PLC
• Terumo Corporation
• XENIOS AG
• OriGen Biomedical
• EUROSETS
• NIPRO
• MicroPort Scientific Corporation

第 10 章

• 调查方法
• 关于出版商

Extracorporeal membrane oxygenation (ECMO) assists cardiopulmonary functions outside the body. Based on the location of drainage and reinfusion there are three different types of extracorporeal membrane oxygenation system which are arteriovenous, venoarterial, and venovenous. Whereas, on the bases of age, ECMO systems are classified into neonatal, pediatric and adult. . The location of drainage and reinfusion port of cannulas determines the modality of the ECMO system. If drainage and reinfusion both are from central veins it is referred as venovenous ECMO or if it is from vein to artery it is referred to as venoarterial ECMO. ECMO is helpful for people who are very ill with conditions of the lungs and heart, or who are awaiting for or recovering from a heart transplant. It may be used when other life support measures do not work. ECMO does not treat or cure a disease, but can assist the body temporarily when it is not able to provide the tissues with enough oxygen.

Growing number of congenital heart defects, increase demand for ECMO. For instance, according to American Heart Association, approximately 40,000 infants are born with a congenital heart defect in U.S. each year and around 2 to 3 million individuals are living with a congenital heart defect.

Market Dynamics

Growth of ECMO market is due to factors such as increasing prevalence of cardiovascular and chronic respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), occupational lung disease or pulmonary hypertension. For instance, according to data published by the World Health Organization, in May 2022, chronic obstructive pulmonary disease (COPD) is the third leading cause of death worldwide, causing 3.23 million deaths in 2019.

Key features of the study:

• This report provides in-depth analysis of the global extracorporeal membrane oxygenation system market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
• It profiles key players in the global extracorporeal membrane oxygenation system market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
• Key companies covered as a part of this study include Medtronic, Getinge AB, LivaNova PLC, Terumo Corporation, XENIOS AG, OriGen Biomedical, EUROSETS NIPRO, and MicroPort Scientific Corporation
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
• The global extracorporeal membrane oxygenation system market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global extracorporeal membrane oxygenation system market

Detailed Segmentation:

• Global Extracorporeal Membrane Oxygenation System Market, By Modality:
  • Arteriovenous
  • Venoarteial
  • Venovenous
• Global Extracorporeal Membrane Oxygenation System Market, By Application:
  • Extracorporeal cardiopulmonary resuscitation
  • Cardiac
  • Respiratory
• Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
  • Neonatal
  • Pediatric
  • Adults
• Global Extracorporeal Membrane Oxygenation System Market, By Region:
  • North America
    • By Country
  • U.S.
  • Canada
  • Latin America
    • By Country
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • By Country
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • By Country
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East
    • By Country
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • By Region/Country
  • South Africa
  • Central Africa
  • North Africa
• Company Profiles
  • Medtronic
    • Company Highlights
    • Products Portfolio
    • Key Highlights
    • Financial Performance
    • Strategies
  • Getinge AB
  • LivaNova PLC
  • Terumo Corporation
  • XENIOS AG
  • OriGen Biomedical
  • EUROSETS
  • NIPRO
  • MicroPort Scientific Corporation

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
  • Market Definition and Scope
• Executive Summary
  • Market Snapshot, By Modality
  • Market Snapshot, By Application
  • Market Snapshot, By Age Group
  • Market Snapshot, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
  • Drivers
  • Restraints
  • Market Opportunities
• Impact Analysis
• Market Trends
• Technological Advancements
• PEST Analysis
• PORTER'S Five Forces

4. Global Extracorporeal Membrane Oxygenation System Market- Impact of Coronavirus (Covid-19) Pandemic

• Overall Impact
• Impact on Supply and Demand
• COVID-19 Impact on the market

5. Global Extracorporeal Membrane Oxygenation System Market, By Modality, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Arteriovenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Venoarteial
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Venovenous
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Extracorporeal Membrane Oxygenation System Market, By Application, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Extracorporeal cardiopulmonary resuscitation
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Cardiac
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Respiratory
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Extracorporeal Membrane Oxygenation System Market, By Age Group, 2017 - 2030, (US$ Million)

• Overview
  • Market Share Analysis, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, 2017 - 2030
  • Segment Trends
• Neonatal
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Pediatric
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
• Adults
  • Overview
  • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

8. Global Extracorporeal Membrane Oxygenation System Market, By Region, 2017 - 2030, (US$ Million)

• Introduction
  • Market Share Analysis, By Region, 2022 and 2030 (%)
  • Y-o-Y Growth Analysis, For Regions, 2017-2030
  • Regional Trends
• North America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• U.S.
• Canada
• Latin America
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• Brazil
• Mexico
• Argentina
• Rest of Latin America
• Europe
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• UK
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
• GCC
• Israel
• Rest of Middle East
• Africa
  • Introduction
  • Market Size and Forecast, and Y-o-Y Growth, By Modality, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Application, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
  • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
• North Africa
• Central Africa
• South Africa

9. Competitive Landscape

• Medtronic
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Getinge AB
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• LivaNova PLC
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• Terumo Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• XENIOS AG
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• OriGen Biomedical
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• EUROSETS
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• NIPRO
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies
• MicroPort Scientific Corporation
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Market Strategies

10. Section

• Research Methodology
• About Us